456 related articles for article (PubMed ID: 29782640)
1. Drug-gut microbiota interactions: implications for neuropharmacology.
Walsh J; Griffin BT; Clarke G; Hyland NP
Br J Pharmacol; 2018 Dec; 175(24):4415-4429. PubMed ID: 29782640
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis.
Kiouptsi K; Reinhardt C
Br J Pharmacol; 2018 Dec; 175(24):4439-4449. PubMed ID: 30129122
[TBL] [Abstract][Full Text] [Related]
3. Microbial biotransformations in the human distal gut.
Bik EM; Ugalde JA; Cousins J; Goddard AD; Richman J; Apte ZS
Br J Pharmacol; 2018 Dec; 175(24):4404-4414. PubMed ID: 29116650
[TBL] [Abstract][Full Text] [Related]
4. When pharmacology meets the microbiome: new targets for therapeutics?
Hyland NP; Cryan JF
Br J Pharmacol; 2018 Dec; 175(24):4401-4403. PubMed ID: 30478976
[TBL] [Abstract][Full Text] [Related]
5. Finding the needle in the haystack: systematic identification of psychobiotics.
Bambury A; Sandhu K; Cryan JF; Dinan TG
Br J Pharmacol; 2018 Dec; 175(24):4430-4438. PubMed ID: 29243233
[TBL] [Abstract][Full Text] [Related]
6. Microbiota-dependent and -independent effects of dietary fibre on human health.
Cai Y; Folkerts J; Folkerts G; Maurer M; Braber S
Br J Pharmacol; 2020 Mar; 177(6):1363-1381. PubMed ID: 31663129
[TBL] [Abstract][Full Text] [Related]
7. The roles of gut microbiota and circadian rhythm in the cardiovascular protective effects of polyphenols.
Man AWC; Xia N; Daiber A; Li H
Br J Pharmacol; 2020 Mar; 177(6):1278-1293. PubMed ID: 31465555
[TBL] [Abstract][Full Text] [Related]
8. Eicosanoids in the gastrointestinal tract.
Wallace JL
Br J Pharmacol; 2019 Apr; 176(8):1000-1008. PubMed ID: 29485681
[TBL] [Abstract][Full Text] [Related]
9. Nutraceuticals as modulators of gut microbiota: Role in therapy.
Quigley EMM
Br J Pharmacol; 2020 Mar; 177(6):1351-1362. PubMed ID: 31659751
[TBL] [Abstract][Full Text] [Related]
10. The role of gut microbiota in cerebrovascular disease and related dementia.
Cuartero MI; García-Culebras A; Nieto-Vaquero C; Fraga E; Torres-López C; Pradillo J; Lizasoain I; Moro MÁ
Br J Pharmacol; 2024 Mar; 181(6):816-839. PubMed ID: 37328270
[TBL] [Abstract][Full Text] [Related]
11. Psychotropics and the Microbiome: a Chamber of Secrets….
Cussotto S; Clarke G; Dinan TG; Cryan JF
Psychopharmacology (Berl); 2019 May; 236(5):1411-1432. PubMed ID: 30806744
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function.
Cussotto S; Strain CR; Fouhy F; Strain RG; Peterson VL; Clarke G; Stanton C; Dinan TG; Cryan JF
Psychopharmacology (Berl); 2019 May; 236(5):1671-1685. PubMed ID: 30155748
[TBL] [Abstract][Full Text] [Related]
13. Updating neuropathology and neuropharmacology of monoaminergic systems.
Ramsay RR; De Deurwaerdère P; Di Giovanni G
Br J Pharmacol; 2016 Jul; 173(13):2065-8. PubMed ID: 27302283
[TBL] [Abstract][Full Text] [Related]
14. Interaction between drugs and the gut microbiome.
Weersma RK; Zhernakova A; Fu J
Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
[TBL] [Abstract][Full Text] [Related]
15. The gut microbiome and pharmacology: a prescription for therapeutic targeting of the gut-brain axis.
Leprun PMB; Clarke G
Curr Opin Pharmacol; 2019 Dec; 49():17-23. PubMed ID: 31082716
[TBL] [Abstract][Full Text] [Related]
16. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
Swanson HI
Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice.
Angoa-Pérez M; Zagorac B; Winters AD; Greenberg JM; Ahmad M; Theis KR; Kuhn DM
PLoS One; 2020; 15(1):e0227774. PubMed ID: 31978078
[TBL] [Abstract][Full Text] [Related]
18. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
[TBL] [Abstract][Full Text] [Related]
19. Confounder or Confederate? The Interactions Between Drugs and the Gut Microbiome in Psychiatric and Neurological Diseases.
Michaelis L; Berg L; Maier L
Biol Psychiatry; 2024 Feb; 95(4):361-369. PubMed ID: 37331548
[TBL] [Abstract][Full Text] [Related]
20. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM
Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
